97 related articles for article (PubMed ID: 15688367)
1. High ID2 protein expression correlates with a favourable prognosis in patients with primary breast cancer and reduces cellular invasiveness of breast cancer cells.
Stighall M; Manetopoulos C; Axelson H; Landberg G
Int J Cancer; 2005 Jun; 115(3):403-11. PubMed ID: 15688367
[TBL] [Abstract][Full Text] [Related]
2. Associations and interactions between Ets-1 and Ets-2 and coregulatory proteins, SRC-1, AIB1, and NCoR in breast cancer.
Myers E; Hill AD; Kelly G; McDermott EW; O'Higgins NJ; Buggy Y; Young LS
Clin Cancer Res; 2005 Mar; 11(6):2111-22. PubMed ID: 15788656
[TBL] [Abstract][Full Text] [Related]
3. Expression of E2F-4 in invasive breast carcinomas is associated with poor prognosis.
Rakha EA; Pinder SE; Paish EC; Robertson JF; Ellis IO
J Pathol; 2004 Jul; 203(3):754-61. PubMed ID: 15221934
[TBL] [Abstract][Full Text] [Related]
4. Fatty acid binding protein 7 expression and its sub-cellular localization in breast cancer.
Alshareeda AT; Rakha EA; Nolan CC; Ellis IO; Green AR
Breast Cancer Res Treat; 2012 Jul; 134(2):519-29. PubMed ID: 22562177
[TBL] [Abstract][Full Text] [Related]
5. The mRNA expression of inhibitors of DNA binding-1 and -2 is associated with advanced tumour stage and adverse clinical outcome in human breast cancer.
Wazir U; Jiang WG; Sharma AK; Newbold RF; Mokbel K
Anticancer Res; 2013 May; 33(5):2179-83. PubMed ID: 23645773
[TBL] [Abstract][Full Text] [Related]
6. Expression of Id helix-loop-helix proteins in colorectal adenocarcinoma correlates with p53 expression and mitotic index.
Wilson JW; Deed RW; Inoue T; Balzi M; Becciolini A; Faraoni P; Potten CS; Norton JD
Cancer Res; 2001 Dec; 61(24):8803-10. PubMed ID: 11751402
[TBL] [Abstract][Full Text] [Related]
7. Role of Id-2 in the maintenance of a differentiated and noninvasive phenotype in breast cancer cells.
Itahana Y; Singh J; Sumida T; Coppe JP; Parrinello S; Bennington JL; Desprez PY
Cancer Res; 2003 Nov; 63(21):7098-105. PubMed ID: 14612502
[TBL] [Abstract][Full Text] [Related]
8. JAM-A expression positively correlates with poor prognosis in breast cancer patients.
McSherry EA; McGee SF; Jirstrom K; Doyle EM; Brennan DJ; Landberg G; Dervan PA; Hopkins AM; Gallagher WM
Int J Cancer; 2009 Sep; 125(6):1343-51. PubMed ID: 19533747
[TBL] [Abstract][Full Text] [Related]
9. Targeting ID2 expression triggers a more differentiated phenotype and reduces aggressiveness in human salivary gland cancer cells.
Sumida T; Ishikawa A; Nakano H; Yamada T; Mori Y; Desprez PY
Genes Cells; 2016 Aug; 21(8):915-20. PubMed ID: 27364596
[TBL] [Abstract][Full Text] [Related]
10. The protein ENH is a cytoplasmic sequestration factor for Id2 in normal and tumor cells from the nervous system.
Lasorella A; Iavarone A
Proc Natl Acad Sci U S A; 2006 Mar; 103(13):4976-81. PubMed ID: 16549780
[TBL] [Abstract][Full Text] [Related]
11. Targeting Id1 and Id3 by a specific peptide aptamer induces E-box promoter activity, cell cycle arrest, and apoptosis in breast cancer cells.
Mern DS; Hoppe-Seyler K; Hoppe-Seyler F; Hasskarl J; Burwinkel B
Breast Cancer Res Treat; 2010 Dec; 124(3):623-33. PubMed ID: 20191379
[TBL] [Abstract][Full Text] [Related]
12. Constitutive expression of the Id-1 promoter in human metastatic breast cancer cells is linked with the loss of NF-1/Rb/HDAC-1 transcription repressor complex.
Singh J; Murata K; Itahana Y; Desprez PY
Oncogene; 2002 Mar; 21(12):1812-22. PubMed ID: 11896613
[TBL] [Abstract][Full Text] [Related]
13. Novel signaling molecules implicated in tumor-associated fatty acid synthase-dependent breast cancer cell proliferation and survival: Role of exogenous dietary fatty acids, p53-p21WAF1/CIP1, ERK1/2 MAPK, p27KIP1, BRCA1, and NF-kappaB.
Menendez JA; Mehmi I; Atlas E; Colomer R; Lupu R
Int J Oncol; 2004 Mar; 24(3):591-608. PubMed ID: 14767544
[TBL] [Abstract][Full Text] [Related]
14. The helix-loop-helix protein Id2 is overexpressed in human pancreatic cancer.
Kleeff J; Ishiwata T; Friess H; Büchler MW; Israel MA; Korc M
Cancer Res; 1998 Sep; 58(17):3769-72. PubMed ID: 9731481
[TBL] [Abstract][Full Text] [Related]
15. Metastasis tumor antigen family proteins during breast cancer progression and metastasis in a reliable mouse model for human breast cancer.
Zhang H; Stephens LC; Kumar R
Clin Cancer Res; 2006 Mar; 12(5):1479-86. PubMed ID: 16533771
[TBL] [Abstract][Full Text] [Related]
16. Id2 is a retinoblastoma protein target and mediates signalling by Myc oncoproteins.
Lasorella A; Noseda M; Beyna M; Yokota Y; Iavarone A
Nature; 2000 Oct; 407(6804):592-8. PubMed ID: 11034201
[TBL] [Abstract][Full Text] [Related]
17. A role for Id-1 in the aggressive phenotype and steroid hormone response of human breast cancer cells.
Lin CQ; Singh J; Murata K; Itahana Y; Parrinello S; Liang SH; Gillett CE; Campisi J; Desprez PY
Cancer Res; 2000 Mar; 60(5):1332-40. PubMed ID: 10728695
[TBL] [Abstract][Full Text] [Related]
18. Expression of periostin in human breast cancer.
Puglisi F; Puppin C; Pegolo E; Andreetta C; Pascoletti G; D'Aurizio F; Pandolfi M; Fasola G; Piga A; Damante G; Di Loreto C
J Clin Pathol; 2008 Apr; 61(4):494-8. PubMed ID: 17938160
[TBL] [Abstract][Full Text] [Related]
19. Expression of the transcription factor CTCF in invasive breast cancer: a candidate gene located at 16q22.1.
Rakha EA; Pinder SE; Paish CE; Ellis IO
Br J Cancer; 2004 Oct; 91(8):1591-6. PubMed ID: 15354217
[TBL] [Abstract][Full Text] [Related]
20. Differential subcellular localisation of the tumour suppressor protein LIMD1 in breast cancer correlates with patient survival.
Spendlove I; Al-Attar A; Watherstone O; Webb TM; Ellis IO; Longmore GD; Sharp TV
Int J Cancer; 2008 Nov; 123(10):2247-53. PubMed ID: 18712738
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
